史客松

出生年月

1995年03月

单位

英国上市公司365,英国上市公司365

所属学科

临床医学-肿瘤学

职称、职务

讲师

E-mail

sg1033425914@163.com

研究方向

肿瘤进展的分子机制与治疗干预

个人简介

史客松，博士，讲师。发表SCI收录论文10余篇，其中以第一作者或通讯作者身份发表SCI论文5篇。担任《European Journal of Medical Research》、《Cell Biology International》等多个SCI期刊的审稿人。主持湖北省自然科学基金（青年B类项目）1项，并参与国家自然科学基金面上项目1项。

代表作

①Shi K, Chen Y, Gao T, Guo H, Fu X, Wu Y, Yu H. The Oncogenic Role of UBXN1 in Gastric Cancer Is Attributed to the METTL16-Mediated m6A Methylation and Histone Modifications. Cancer Med. 2025 Mar;14(6):e70772. doi: 10.1002/cam4.70772.

②Shi K, Chen Y, Liu R, Fu X, Guo H, Gao T, Wang S, Dou L, Wang J, Wu Y, Yu J, Yu H. NFIC mediates m6A mRNA methylation to orchestrate transcriptional and post-transcriptional regulation to represses malignant phenotype of non-small cell lung cancer cells. Cancer Cell Int. 2024 Jun 28;24(1):223.  

③Shi K, Sa R, Dou L, Wu Y, Dong Z, Fu X, Yu H. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma. Clin Epigenetics. 2023 Sep 23;15(1):153.                        

④Shi K, Wang B, Dou L, Wang S, Fu X, Yu H. Integrated bioinformatics analysis of the transcription factor-mediated gene regulatory networks in the formation of spermatogonial stem cells. Front Physiol. 2022 Dec 8;13:949486. doi: 10.3389/fphys.2022.949486.